A rare case of eptifibatide-induced thrombocytopenia

• Váldodahkkit: Khalil Kamar (Dahkki), Kira MacDougall (Dahkki), Mira Alsheikh (Dahkki), Sara Parylo (Dahkki), Yevgeniy Skaradinskiy (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Greater Baltimore Medical Center, 2021-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Eptifibatide is a glycoprotein (GP) IIb/IIIa receptor antagonist, used for the treatment of acute coronary syndrome with high-risk features or ongoing ischemia. Several case reports have described thrombocytopenia as a rare side effect of eptifibatide administration. The exact mechanism remains uncl...